%0 Journal Article
%T Contribution of Computed Tomography in the Diagnosis of Pulmonary Lesions Due to Coronavirus Disease (SRAS-CoV-2), COVID-19
%A Abdoulaye Kon¨¦
%A Saloum Gand¨¦ga
%A Youssouf Kon¨¦
%A Moussa Traor¨¦
%A Moussa Konat¨¦
%A Jean Paul Demb¨¦l¨¦
%A Ouncoumba Diarra
%A Ibrahima Coulibaly
%A Youssouf Diawara
%A Cheick Oumar Tour¨¦
%A Kassim Sidib¨¦
%A Mody A. Camara
%A Oumar Aba Ata
%A Yacouba Toloba
%A Jean Steiner
%A Mahamadou Diallo
%A Adama Diaman Keita
%A Salia Coulibaly
%A Siaka Sidibe
%J Open Journal of Radiology
%P 68-77
%@ 2164-3032
%D 2022
%I Scientific Research Publishing
%R 10.4236/ojrad.2022.123008
%X Our study was carried out at Robert BALLANGER Hospital, its aim was to determine the contribution of the scanner in the diagnosis of COVID-19. It was a prospective descriptive study during the first wave of the COVID-19 epidemic in France. Patients were referred to the medical imaging department for a thoracic CT scan without contrast injection or an angioscanner in the context of a suspected COVID-19 pneumopathy or pulmonary embolism. The study involved both sexes, the male sex was with 55.20% and sex ratio of 1.24. In our study 50% of our patients had a comorbid factor, of which diabetes and hypertension were the most represented with 33% and 17%. The RT PRC test is considered the gold standard in the diagnosis of COVID-19 disease. This test was positive in 63.62% of our patients. CT imaging played a key role in the management of COVID-19 pneumonia because chest CT scans found lesions consistent with COVID-19 pneumonia in 71% of patients. The depoliated lung lesion was present in 87% of our patients, with sub pleural topography and minimal parenchymal involvement predominating. In our study, the chest CT scan had a higher sensitivity and a lower specificity than the PCR test.
%K Contribution
%K CT
%K COVID-19
%K SARS-CoV-2
%K Diagnosis
%K Lungs
%K France
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=119731